← Company intelligence

Robot maker · registered

Axiles Bionics

Corporate marketwearablesCurated record

AI-adaptive powered ankle-foot prosthesis; embedded sensors measure user intent, terrain type, and loading in real-time; control algorithms modulate ankle stiffness and power injection each step to replicate biological ankle behaviour; Lunaris IO+ adds smart connectivity for clinician remote tuning; patented elastic tendon mimics Achilles tendon with 39-degree ROM; battery-fail-safe design allows continued passive use when unpowered.

HeadquartersBrussels, BE
Founded2019
Corporate funding$12M
Team11-50
Deployments1
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries A
FoundersPierre Cherelle (Founder & CEO)
Regions servedEurope
Countries deployedBE
Service footprintAI-adaptive powered ankle-foot prostheses (Lunaris Essential, IO, IO+) for below-knee amputees; VUB spin-off; distributed through prosthetists and clinics in Europe; Brussels, Belgium.
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinewearables

Lunaris Essential

  • 27° range of motion

    vendor-stated ankle ROM for the Essential model; high-grade engineering balancing precision and accessibility

    Claim source
  • Covered by most European reimbursement systems

    vendor-stated insurance reimbursement status across European markets as of launch in September 2024

    Claim source
Machinewearables

Lunaris IO

  • 39° range of motion

    vendor-stated ankle ROM; mimics biological Achilles tendon via elastic tendon mechanism

    Claim source
  • 14 embedded sensors with mobile app data insights

    vendor-stated sensor count enabling gait data logging and clinician remote monitoring

    Claim source
  • 25% lighter than original Lunaris

    vendor-stated weight reduction versus first-generation Lunaris (pre-2024 model)

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2023-01-19Commercial prosthetic patients (Belgium, France, Luxembourg, Netherlands)prosthetics_clinicBENot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordPE GroupEIC FundFinance&Invest.brussels
TL

Company timeline

Milestones and announcements

2025-06-24Closed first €6M tranche of €8M Series A led by PE Group, with EIC Fund and Finance&Invest.brussels co-investing, to scale Lunaris distribution and advance smart bionic foot developmentAxiles Bionics
2024-09-01Launched new Lunaris product line: Lunaris Essential (27° ROM, covered by most European reimbursement), Lunaris IO (39° ROM, 14 sensors, 25% lighter), and Lunaris IO+ (OTA updates); CE-marked and FDA-cleared at launchAxiles Bionics
2022-11-02Lunaris prosthetic foot received CE mark (EU MDR): registered with Belgian FAMHP; authorized as medical device manufacturer across the European UnionAxiles Bionics
SC

Source ledger

8 unique public sources